Search Results For ''

  • ‘Working from home’ here to stay as productive Australians focus on wellbeing

    Among the many unknowns to emerge from the pandemic, the working from home phenomenon has plagued executive management but questions as to whether it would become the norm have been categorically answered with a resounding YES. Surveys have shown that working from home improves productivity and contributes to a better work life balance. Not having

    Read More
    Public
  • Genetic Technologies launches AI-based COVID Risk Test

    Personalised medicine is quickly becoming the new standard of healthcare thanks to the ease of genetic testing and technological advancements. Genetic Technologies (ASX: GTG) is pioneering a preventative, individualised approach to the COVID-19 pandemic through their experience in genomics and AI driven preventative health. Having already created genetic testing kits to predict breast and colorectal

    Read More
    Public
  • Adherium submits FDA application for smart inhaler to digitise respiratory treatment

    Sufferers of asthma and COPD in the United States could soon have access to a digital inhaler device that will alert them when they have not inhaled enough medication as part of their treatment program with medtech company Adherium (ASX: ADR) submitting an FDA application for their device.  The application is for their Hallie® product,

    Read More
    Public
  • Nuix confirms profit downgrade as shares keep tumbling with class action pending

    Embattled forensic software and data analytics company Nuix (ASX: NXL) is deep in damage control following media reports of questionable practices, today downgrading their revenue forecasts, citing “uncertainty” in their ability to convert upsell opportunities.  The market update revises Nuix’s FY21 pro-forma revenue forecast to $173m-$182m, having previously forecast $180m-$185m in April 2021. Pro-forma EBITDA

    Read More
    Public
  • Avecho Biotechnology expands their proprietary drug delivery system to livestock

    Necessity is the mother of all invention, and seeing an opportunity, Avecho Biotechnology (ASX: AVE) has set about innovating a new livestock feed additive. The development of a new feed additive for animal use comes in anticipation of the European Union’s impending ban on livestock feeds with zinc oxide levels above a certain level. Zinc

    Read More
    Public
  • Small Caps Watch – Harris Technology CEO Garrison Huang

    In this episode of Small Caps Watch, we are joined by the CEO and Managing Director of Harris Technology (ASX: HT8) as he provides an overview of the company’s eCommerce, their recent success, and plans for the future. Click below to watch. Harris Technology invites investors to join their mailing list for Company updates and

    Read More
    Public